Newswise Blockbuster weight-loss drugs are transforming the way we treat obesity
Obesity is being reframed as a disease, not just a lifestyle choice
However, this is unlikely to reflect the physiological situation under which the central GLP1 system evolved, and thus, it will be important to determine whether PPG neurons are indeed only a secondary satiation system under more naturalistic feeding conditions in rodents and humans
Check out a few of the many people that we have helped reach their ideal weight goals over the years.
But if you are taking a glucagon-like peptide-1 (GLP-1) drug for weight loss, the protocol for getting back on track may be different than missing a dose of antibiotics
The GLP-1 mediated signaling in the brain that makes us less hungry and less interested in food, makes us less compulsive - not just about eating but about a lot of different things